TIAA CREF INVESTMENT MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,010,000
-12.9%
64,068
+11.1%
0.00%0.0%
Q4 2018$1,160,000
-69.2%
57,645
-61.9%
0.00%0.0%
Q3 2018$3,762,000
+22.8%
151,370
+35.6%
0.00%
-50.0%
Q2 2018$3,064,000
+47.9%
111,620
+66.0%
0.00%
+100.0%
Q1 2018$2,071,000
-7.8%
67,235
+7.0%
0.00%0.0%
Q4 2017$2,247,000
+35.7%
62,863
+4.6%
0.00%0.0%
Q3 2017$1,656,000
+5.4%
60,104
+1.0%
0.00%0.0%
Q2 2017$1,571,000
+0.3%
59,509
-20.9%
0.00%0.0%
Q1 2017$1,566,000
-2.6%
75,274
-3.1%
0.00%0.0%
Q4 2016$1,608,000
+39.5%
77,687
+9.2%
0.00%0.0%
Q3 2016$1,153,000
+37.6%
71,153
+15.5%
0.00%0.0%
Q2 2016$838,000
-13.9%
61,589
+10.5%
0.00%0.0%
Q1 2016$973,000
-48.9%
55,7150.0%0.00%0.0%
Q4 2015$1,903,000
+21.8%
55,715
+6.1%
0.00%0.0%
Q3 2015$1,563,000
-9.0%
52,528
-2.2%
0.00%0.0%
Q2 2015$1,717,000
+161.7%
53,683
+69.7%
0.00%
Q1 2015$656,000
+31.7%
31,633
+7.6%
0.00%
Q4 2014$498,000
-10.8%
29,393
+1.8%
0.00%
Q3 2014$558,000
-43.2%
28,8720.0%0.00%
-100.0%
Q2 2014$982,000
+41.3%
28,872
+30.8%
0.00%0.0%
Q1 2014$695,00022,0780.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders